Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30

$10.65−2.70 (-20.22%)

Close on Nov 12, 2026Market cap $275.20MP/E –Yield –

Faeth Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Faeth Therapeutics's total debt was $567.00K at Jun 30, 2021. For fiscal 2020 it was $567.00K.

Period	Period end	Value	Change
FY2020	Dec 31, 2020	$567.00K	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2021	Jun 30, 2021	$567.00K	–
Q1 FY2021	Mar 31, 2021	$567.00K	–
Q4 FY2020	Dec 31, 2020	$567.00K	–

See a number that looks wrong?